11/7/26 From Parent Advocacy to IND: Building a Treatment Pathway for an Ultra-Rare Disease Previous Modeling Value Across the Rare Disease Patient Journey Next Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors Who Really Decides Which Rare Disease Therapies Survive: Regulators, Investors, Payers, or Patients? Learning More from Less: Smarter Design and Execution in Rare Disease Trials From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development
11/7/26 From Parent Advocacy to IND: Building a Treatment Pathway for an Ultra-Rare Disease Previous Modeling Value Across the Rare Disease Patient Journey Next Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors Who Really Decides Which Rare Disease Therapies Survive: Regulators, Investors, Payers, or Patients? Learning More from Less: Smarter Design and Execution in Rare Disease Trials From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development
